All In Biotech

Drug Trial Radar · NCT06038578

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

A Randomized, Multicenter, Open-Label, Phase 2 Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 146 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

146

Planned (sponsor's estimate)

Start

Oct 4, 2023

Primary completion

Oct 31, 2027

Study completion Oct 31, 2027

Sponsor

Lead sponsor
Toray Industries, IncIndustry
Sponsor type
Industry
First posted
Sep 15, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the efficacy, safety, optimal dose and ADA and NAbs development of TRK-950 at two separate dose levels in combination with ramucirumab and paclitaxel (RAM+PTX) as compared with RAM + PTX treatment alone in participants with gastric or gastro-esophageal junction (GEJ) adenocarcinoma.

Conditions

  • Gastric Adenocarcinoma
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma

Interventions

  • TRK-950Biological

    5 mg/kg or 10 mg/kg IV infusion over 60 minutes on Day 1, 8, 15 and 21 of each 28 day cycle

  • RamucirumabDrug

    8 mg/kg IV infusion on Days 1 and 15 of a 28-day cycle

  • PaclitaxelDrug

    80 mg/m\^2 IV infusion on Days 1, 8, and 15 of a 28-day cycle

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression free Survival (PFS)Time frame: Time from date of randomization to the date of progressive disease or death due to any cause, whichever occurs first, up to approximately 24 months

Locations

27 sites in 3 countries. Site status is shown where the registry gives one.

  • City of Hope

    Duarte, California · Recruiting

  • City of Hope at Orange County Lennar Foundation Cancer Center

    Irvine, California · Recruiting

  • University of California, Los Angeles

    Santa Monica, California · Recruiting

  • Texas Oncology Arlington North

    Arlington, Texas · Recruiting

  • Texas Oncology Bedford

    Bedford, Texas · Recruiting

  • Texas Oncology Dallas Methodist

    Dallas, Texas · Recruiting

  • Texas Oncology Dallas Medical City

    Dallas, Texas · Recruiting

  • Texas Oncology Dallas Presbyterian

    Dallas, Texas · Recruiting

  • Texas Oncology Methodist Charlton Cancer Center

    Dallas, Texas · Recruiting

  • Texas Oncology-Sammons Cancer Center

    Dallas, Texas · Recruiting

  • Texas Oncology Fort Worth Cancer Center

    Fort Worth, Texas · Recruiting

  • Texas Oncology Grapevine

    Grapevine, Texas · Recruiting

  • Texas Oncology Plano East

    Plano, Texas · Recruiting

  • Texas Oncology Plano West

    Plano, Texas · Recruiting

  • National Cancer Center Hospital

    Chūōku, Japan · Recruiting

  • Osaka International Cancer Institute

    Chūōku, Japan · Recruiting

  • National Cancer Center Hospital East

    Kashiwa, Japan · Recruiting

  • The Cancer Institute Hospital of JFCR

    Kōtoku, Japan · Recruiting

  • Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center

    Yokohama, Kanagawa, Japan · Recruiting

  • Saitama Prefectural Hospital Organization Saitama Cancer Center

    Shinden, Saitama, Japan · Recruiting

  • Shizuoka Cancer Center

    Nagaizumi-cho, Shizuoka, Japan · Recruiting

  • Kyungpook National University Chilgok Hospital

    Daegu, South Korea · Recruiting

  • Severance Hospital

    Seoul, South Korea · Recruiting

  • ASAN Medical Center

    Seoul, South Korea · Recruiting

  • Samsung Medical Center

    Seoul, South Korea · Recruiting

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, South Korea · Recruiting

  • Chonnam National University Hwasun Hospital

    Hwasun, Jeollanam-do, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.